568 related articles for article (PubMed ID: 15770660)
1. Clinical and molecular aspects of the myotonic dystrophies: a review.
Machuca-Tzili L; Brook D; Hilton-Jones D
Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
[TBL] [Abstract][Full Text] [Related]
2. RNA pathogenesis of the myotonic dystrophies.
Day JW; Ranum LP
Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
[TBL] [Abstract][Full Text] [Related]
3. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
4. [Myotonic dystrophy].
Nanba E
Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
Kumar A; Agarwal S; Agarwal D; Phadke SR
Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
[TBL] [Abstract][Full Text] [Related]
6. [Molecular pathways to myotonic dystrophy].
Ishiura S
Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
[TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; altered RNA processing as a cause of myotonic dystrophy type 1].
de Die-Smulders CE; Faber CG; Smeets HJ
Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2043-6. PubMed ID: 16184945
[TBL] [Abstract][Full Text] [Related]
8. The expanding clinical and genetic spectrum of the myotonic dystrophies.
Ricker K
Acta Neurol Belg; 2000 Sep; 100(3):151-5. PubMed ID: 11098287
[TBL] [Abstract][Full Text] [Related]
9. Myotonic dystrophies.
Huang CC; Kuo HC
Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
[TBL] [Abstract][Full Text] [Related]
10. Myotonic dystrophies type 1 and 2: a summary on current aspects.
Schara U; Schoser BG
Semin Pediatr Neurol; 2006 Jun; 13(2):71-9. PubMed ID: 17027856
[TBL] [Abstract][Full Text] [Related]
11. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.
Kaliman P; Llagostera E
Cell Signal; 2008 Nov; 20(11):1935-41. PubMed ID: 18583094
[TBL] [Abstract][Full Text] [Related]
12. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
13. Upgrading molecular diagnostics of myotonic dystrophies: multiplexing for simultaneous characterization of the DMPK and ZNF9 repeat motifs.
Radvansky J; Ficek A; Kadasi L
Mol Cell Probes; 2011 Aug; 25(4):182-5. PubMed ID: 21550396
[TBL] [Abstract][Full Text] [Related]
14. Cerebral involvement in myotonic dystrophies.
Meola G; Sansone V
Muscle Nerve; 2007 Sep; 36(3):294-306. PubMed ID: 17486579
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
[TBL] [Abstract][Full Text] [Related]
16. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
[TBL] [Abstract][Full Text] [Related]
17. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
Meola G; Cardani R
Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
[TBL] [Abstract][Full Text] [Related]
18. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
Finsterer J; Rudnik-Schöneborn S
Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
[TBL] [Abstract][Full Text] [Related]
19. Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function.
Mulders SA; van Engelen BG; Wieringa B; Wansink DG
Hum Mol Genet; 2010 Apr; 19(R1):R90-7. PubMed ID: 20406734
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]